Pandemic influenza: A never-ending story

Yonago Acta Medica

Volumn 54, Issue 3, 2011, Pages 41-48

  Kageyama, Seiji ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Emergence; Influenza; Pandemic; Prevention; Treatment

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; LANINAVIR; OSELTAMIVIR; PENICILLIN G; PERAMIVIR; UNCLASSIFIED DRUG; ZANAMIVIR;

1977 RUSSIAN INFLUENZA; 2009 H1N1 INFLUENZA; AGE DISTRIBUTION; ANTIGEN DETECTION; ASIAN INFLUENZA; CLINICAL FEATURE; DISEASE DURATION; EVIDENCE BASED PRACTICE; FEVER; GENETIC ASSOCIATION; HAND WASHING; HONG KONG INFLUENZA; HOUSEHOLD; HUMAN; IMMUNIZATION; INFECTION CONTROL; MASK; MEDICAL LITERATURE; MORTALITY; NORTHERN HEMISPHERE; PANDEMIC INFLUENZA; PREVENTIVE MEDICINE; PROTECTIVE CLOTHING; REVIEW; SEASONAL INFLUENZA; SEASONAL VARIATION; SOUTHERN HEMISPHERE; SPANISH INFLUENZA; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 83455258125     PISSN: 05135710     EISSN: 13468049     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Aiello AE, Murray GF, Perez V, Coulborn RM, Davis BM, Uddin M, et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Dis 2010;201:491-498.
2. Baker M, Kelly H, Wilson N. Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill 2009;14.
3. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-1719.
4. Boltz DA, Aldridge JR, Jr., Webster RG, Govorkova EA. Drugs in development for influenza. Drugs 2010; 70:1349-1362.
5. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. Lancet Infect Dis 2007;7:257-265.
6. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361:2507-2517.
7. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008;167:775-785.
8. CDC. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus- United States, 2009. MMWR Morb Mortal Wkly Rep 2009a;58:826-829.
9. CDC. Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009b;58:400-402.
10. Cowling BJ, Zhou Y, Ip DK, Leung GM, Aiello AE. Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol Infect 2009;138:449-456.
11. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615.
12. Falagas ME, Cholevas NV, Kapaskelis AM, Vouloumanou EK, Michalopoulos A, Rafailidis PI. Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis 2010;29:1327-1347.
13. Falagas ME, Koletsi PK, Baskouta E, Rafailidis PI, Dimopoulos G, Karageorgopoulos DE. Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience. Epidemiol Infect 2011;139:27-40.
14. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 2006;442:448-452.
15. Fichera E, Felnerova D, Mischler R, Viret JF, Glueck R. New strategies to overcome the drawbacks of currently available flu vaccines. Adv Exp Med Biol 2009;655:243-252.
16. Australian Government Department of Health and Ageing. Australian influenza surveillance summary report. 2009;No.17:1-20.
17. Guan Y, Vijaykrishna D, Bahl J, Zhu H, Wang J, Smith GJ. The emergence of pandemic influenza viruses. Protein Cell 2010;1:9-13.
18. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-1952.
19. Inoue M, Barkham T, Leo YS, Chan KP, Chow A, Wong CW, et al. Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours. Emerg Infect Dis 2010;16:1633-1636.
20. Kamigaki T, Oshitani H. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr 2009;1:RRN1139.
21. Killingley B, Enstone J, Booy R, Hayward A, Oxford J, Ferguson N, et al.; on behalf of the influenza transmission strategy development group. Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect Dis 2011 July 26. [Epub ahead of print]
22. Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med 2010;363:2036-2044.
23. Lau LL, Cowling BJ, Fang VJ, Chan KH, Lau EH, Lipsitch M, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010;201:1509-1516.
24. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P. A community cluster of oseltamivir- resistant cases of 2009 H1N1 influenza. N Engl J Med 2010;362:86-87.
25. Li CC, Wang L, Eng HL, You HL, Chang LS, Tang KS, et al. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis 2010;16:1265-1272.
26. Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010;50:963-969.
27. Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM. Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med 2009;361:112-115.
28. MacIntyre CR, Cauchemez S, Dwyer DE, Seale H, Cheung P, et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis 2009;15:233-241.
29. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008;198:962-970.
30. Muscatello DJ, Barr M, Thackway SV, Macintyre CR. Epidemiology of influenza-like illness during pandemic (H1N1) 2009, New South Wales, Australia. Emerg Infect Dis 2011;17:1240-1247.
31. Nishiura H. Case fatality ratio of pandemic influenza. Lancet Infect Dis 2010;10:443-444.
32. New South Wales public health network. Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveill 2009;14(42): pii=19365.
33. Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, et al. Pandemic influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill 2010;15(20): pii=19571.
34. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009;360:2616-2625.
35. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009;459:1122-1125.
36. Sreta D, Tantawet S, Na Ayudhya SN, Thontiravong A, Wongphatcharachai M, Lapkuntod J, et al. Pandemic (H1N1) 2009 virus on commercial swine farm, Thailand. Emerg Infect Dis 2010;16:1587-1590.
37. Talaat M, Afifi S, Dueger E, El-Ashry N, Marfin A, Kandeel A, et al. Effects of hand hygiene campaigns on incidence of laboratory-confirmed influenza and absenteeism in schoolchildren, Cairo, Egypt. Emerg Infect Dis 2011;17:619-625.
38. Taubenberger JK, Morens DM. Influenza: the once and future pandemic. Public Health Rep 2010;125 Suppl 3:16-26.
39. Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med 2009;361:115-119.
40. van der Vries E, Stelma FF, Boucher CA. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med 2010;363:1381-1382.
41. Widmer N, Meylan P, Ivanyuk A, Aouri M, Decosterd LA, Buclin T. Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics. Clin Pharmacokinet 2010;49:741-765.
42. Wilking H, Buda S, von der Lippe E, Altmann D, Krause G, Eckmanns T, et al. Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill 2010;15(49): pii=19741.
43. World Health Organization. Considerations for assessing the severity of an influenza pandemic. Wkly Epidemiol Rec 2009;84:197-202.
44. Zimmer SM, Burke DS. Historical perspective-Emergence of influenza A (H1N1) viruses. N Engl J Med 2009;361:279-285.